Skip to content
  • Tuesday, 27 October 2026
  • 11:29 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Navigating the Critical Transition from Laboratory Bench to GMP Fill-Finish CDMO Operations
Pharmaceutical R&D

Navigating the Critical Transition from Laboratory Bench to GMP Fill-Finish CDMO Operations

Teuku Ryan Oct 27, 2026 0

The transition of a breakthrough therapeutic compound from an exploratory research laboratory to a clinical-grade Good Manufacturing Practice (GMP) environment…

Read More
Laboratory Safety & Compliance

Before You Correct, Connect: The Art of Laboratory Safety Coaching

Layla Zulfa Oct 26, 2026 0

The modern laboratory environment is a complex ecosystem of high-stakes precision, stringent regulatory requirements, and technical expertise. Within this high-pressure…

Read More
Laboratory Safety & Compliance

Beyond the Statistics: Analyzing the Evolution of Safety in the Modern Clinical Laboratory

Layla Zulfa Oct 24, 2026 0

Every year, the Bureau of Labor Statistics (BLS) releases its annual Survey of Occupational Injuries and Illnesses, and for the…

Read More
Laboratory Safety & Compliance

Part 2: Is Your Laboratory Really Ready?

Layla Zulfa Oct 21, 2026 0

In the modern landscape of clinical medicine, the ability of a laboratory to respond to a highly infectious disease (HID)…

Read More
Laboratory Safety & Compliance

Part 2: Is Your Laboratory Really Ready?

Layla Zulfa Oct 13, 2026 0

The operational integrity of a clinical laboratory hinges not on the constant acquisition of high-end, specialized infrastructure, but on the…

Read More
Laboratory Safety & Compliance

Navigating the Regulatory Complexity of Formaldehyde Exposure Monitoring in Modern Laboratory Environments

Layla Zulfa Oct 11, 2026 0

The use of passive dosimeter badges for monitoring formaldehyde exposure in laboratory settings has long been a cornerstone of industrial…

Read More
Laboratory Safety & Compliance

Part 2: Is Your Laboratory Really Ready?

Layla Zulfa Oct 5, 2026 0

Preparing for the arrival of a patient with a highly infectious disease (HID) is a critical component of modern healthcare…

Read More
Laboratory Safety & Compliance

Beyond the Data: Why National Laboratory Safety Trends Mask Localized Risks

Layla Zulfa Oct 5, 2026 0

Every year, the U.S. Bureau of Labor Statistics (BLS) releases its annual Survey of Occupational Injuries and Illnesses, and for…

Read More
Pharmaceutical R&D

Beyond the Laboratory: How the GLP-1 Boom and Injectable Demand Expose a Global Manufacturing Bottleneck

Teuku Ryan Oct 2, 2026 0

The pharmaceutical industry is currently experiencing a Golden Age of biologic therapies, driven by groundbreaking scientific innovations, expanding clinical indications,…

Read More
Laboratory Safety & Compliance

Part 2: Is Your Laboratory Really Ready?

Layla Zulfa Sep 28, 2026 0

Preparing for the arrival of a highly infectious disease (HID) within a clinical laboratory setting requires a transition from reactive…

Read More

Posts pagination

1 2 … 4
Stanford University Study Reveals Gerozyme Inhibitor Capable of Regenerating Damaged Knee Cartilage and Halting Osteoarthritis ProgressionAkeso Secures NMPA Approval for Gumokimab to Treat Plaque Psoriasis in ChinaAnthropic’s Claude helped plan work with bird flu, but it’s unclear if harm was intendedTWiV 1291: A Foot in the Door for Cytomegalovirus
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Merck and Moderna’s cancer vaccine is customized for each patient’s tumorAn Unbiased Look at Google Gemini Omni: Features, Costs, and Market ComparisonESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial CancerLight-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison
Evan Lee Salim Oct 27, 2026
Pharmaceutical R&D
ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ